Know which molecule to enter next.
For manufacturers and private-label companies without a regulatory-intelligence team. See whether you can make a molecule, source its active ingredient from certified suppliers, register it and sell it, with the official evidence behind every answer.
Early members are first in line for the pilot. We use your email only to contact you about Molentry, and will delete it on request to admin@molentry.com.
Illustrative preview
Four questions. One answer.
Before you commit a production line and a registration budget to a molecule, four things need to be true. Molentry checks all four in one place.
Make
Match molecules to the dosage forms your lines can actually produce, so every suggestion is buildable.
Source
See how many certified manufacturers supply the active ingredient, and whether you would depend on just one.
Register
Find where it is already approved, and which of those approvals can speed up registration in your market.
Sell
Check patents, exclusivities and generic competition, so you know when the door is open.
See supply risk before you commit.
A promising molecule can stall if only one certified manufacturer makes its active ingredient. Molentry counts the certified sources and flags single-source risk before it turns into a delayed launch.
Built for companies without a big regulatory team.
Local manufacturers
Find off-patent molecules that fit your lines and your markets, ranked with the reasons shown.
Private-label companies
Choose products with reliable, certified supply behind them before you sign with a contract manufacturer.
Distributors
Compare your portfolio against a global reference and see which gaps are worth filling.
Built on public regulatory records. Every answer cites its source and retrieval date. Molentry is independent and not affiliated with any regulatory authority.
Be first in line for the pilot.
Molentry launches in 2027. A small group of early companies will shape it first.